Different impact of high-density lipoprotein-related genetic variants on polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population

Abstract Neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) are both major serosanguinous maculopathies among the Asian elderly. They are similar in phenotype. Genetic variants in high-density lipoprotein (HDL) pathway were discovered to be associated with AMD in two genome-wide association studies. In this study with a Chinese Han cohort, we investigated the impacts of these genetic variants on nAMD and PCV separately. The missense coding variants and previously identified variants at LIPC , ABCA1 , CETP , LPL and FADS1 loci were genotyped in 157 nAMD patients, 250 PCV patients and 204 controls without any macular abnormality. The known variants in CFH , ARMS2 and near HTRA1 were also genotyped. Fasting serum cholesterol levels were determined. The variants in CFH , ARMS2 and near HTRA1 were strongly associated with both PCV ( P −6 , 10 −7 and 10 −7 respectively) and nAMD ( P −6 , 10 −16 and 10 −17 respectively). None of the studied HDL-related variants were significantly associated with nAMD. A missense variant in CETP , rs5882, was significantly associated with PCV ( P  = 2.73 × 10 −4 ). The rs5882 GG genotype had a 3.53-fold (95% CI: 1.93–6.45) increased risk for PCV, and conferred a significantly lower serum HDL-cholesterol level for PCV patients than the AA genotype ( P  = 0.048). These results suggest the need to separate PCV from nAMD in association studies especially with Asian cohorts, and that the HDL pathway may involve in the pathogenesis of PCV and nAMD differently.